Position in REPL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,529,519
+$8,747,854 QoQ
Shares Held
2,035,187
+13.0% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. REPL ranks #126 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in REPL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,529,519 | 2,035,187 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $13,781,665 | 1,801,525 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,011,885 | 1,750,194 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $7,103,927 | 1,695,448 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $15,087,405 | 1,624,048 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $16,309,506 | 1,672,770 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,313,254 | 1,429,666 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $15,654,178 | 1,428,301 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,898,937 | 1,210,993 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,736,948 | 1,191,793 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,653,294 | 1,145,112 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,252,748 | 1,008,343 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,595,226 | 800,828 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,609,129 | 827,244 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,016,744 | 699,145 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,830,174 | 685,013 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,451,715 | 540,716 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,208,237 | 542,299 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,218,502 | 524,668 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,805,357 | 499,506 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,049,485 | 469,794 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,178,153 | 431,929 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,531,029 | 380,892 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,694,354 | 290,806 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,254,855 | 211,463 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,812,974 | 181,843 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||